Cellular dormancy in minimal residual disease following targeted therapy. Ruth JR, Pant DK, Pan TC, Seidel HE, et al. Breast Cancer Res 2021;23:63.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ruth JR, Pant DK, Pan TC, Seidel HE, et al. Cellular dormancy in minimal residual disease following targeted therapy. Breast Cancer Res 2021;23:63.
PMID: 34088357